Skip to content

PHARMACIE VANNESTE

Active Private limited companyfounded 2008active for 18 yearsGemeenteplaats 17, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 0806.691.887 subsidiary of

Board

1 director, no change since 2023
Director (not named in the articles), permanent representative
appointed by deed of 29-11-2023 term without a fixed end
earlier manager, until 29-11-2023
listed in the 2025 annual accounts, filed on 15-06-2026
Permanent representatives 1
Permanent representative, for
appointed by deed of 29-11-2023

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director (not named in the articles)

Director
BoardEarliermandate already running before its first mention
Mandates as a list
    • Director, appointed by deed of 25-11-2021, until 29-11-2023
    • Director (not named in the articles), appointed by deed of 29-11-2023, still in office
    • Director, until 25-11-2021

Control

Parent
Equity €579,146
Profit €68,983 in 2025 (profit €96,017 in 2024)
Source: accounts 2025
100%
This company
PHARMACIE VANNESTE
Equity €138,853
Profit €91,542 in 2025

Capital

Contribution
€6,200
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
100%
Owners as a list
    • 2023 to 2024: 100%

Source: lists of holdings in the owners' accounts

Articles of association

deed of 29-11-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant moitié acquéreurs proportionnellement, cessions entre vifs onéreux gratuit volontaires forcées exclusion retrait usufruit…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Thursday of June at 11:00

Next steps